You are using an outdated browser. Please upgrade your browser to improve your experience.
muscular dystrophy-dystroglycanopathy type B5
Disease Summary
Associated Targets (1)
Tbio
1
Mondo Description A congenital muscular dystrophy characterized by autosomal recessive inheritance of muscular dystrophy with variable penetrance of intellectual disability and structural brain abnormalities that has material basis in homozygous or compound heterozygous mutation in the FKRP gene on chromosome 19q13.3.
Uniprot Description A congenital muscular dystrophy characterized by a severe phenotype with inability to walk, muscle hypertrophy, marked elevation of serum creatine kinase, secondary deficiency of laminin alpha2, and a marked reduction in alpha-dystroglycan expression. Only a subset of affected individuals have brain involvements.
Disease Ontology Description A congenital muscular dystrophy characterized by autosomal recessive inheritance of muscular dystrophy with variable penetrance of intellectual disability and structural brain abnormalities that has_material_basis_in homozygous or compound heterozygous mutation in the FKRP gene on chromosome 19q13.3.
Mondo Term and Equivalent IDs
MONDO:0011688: muscular dystrophy-dystroglycanopathy type B5
Download Data for muscular dystrophy-dystroglycanopathy type B5
data still loading...
Counts of Target Development Levels for diseases known to be associated with this disease. If the disease has a valid DOID, targets known to be associated with all child diseases are aggregated. Click "Explore Associated Targets" to view more facets and details for the target list.
Description from Mondo Disease Ontology.
Description from UniProt.
Description from Disease Ontology
DataSources which have contributed target associations to this disease, and the identifiers by which the disease is referenced.
DOID:0110635
MESH:C564691
OMIM:606612
UMLS:C1847759
MONDO:0011688
High level summary of knowledge for a disease, including descriptions and datasource references.